D-1242-2019 Class III Terminated
FDA drug recall D-1242-2019 was initiated by Zydus Pharmaceuticals USA Inc on Apr 22, 2019 and is designated Class III. Reason for recall: Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of… The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 7668 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 1, 2019
- Initiation Date
- Apr 22, 2019
- Termination Date
- Jan 14, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7668 bottles
Product description
Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.
Distribution pattern
Nationwide in the USA
Code information
Lot #: Z803518, Exp 08/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1242-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026